Exploring how certain natural compounds can help treat substance use disorders
Official title: Mass Spectrometry Techniques to Identify and Characterize New Indole/Tryptamine Chemical Probes for Understanding Psychedelics' Therapeutic Mechanism in Substance Use Disorders
Funded at University of Florida · NIH-11070559 · Data updated 2026-11-12
This study is exploring how certain psychedelics might help people struggling with substance use disorders by looking at how they interact with brain receptors, which could lead to better treatment options for those in need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | January 3, 2025 |
| Project end | January 2, 2028 |
| Funding year | 2025 |
| Award (this year) | $43,902 |
| NIH project number | 1F31DA060559-01A1 |
| Project ID | NIH-11070559 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with substance use disorders who are seeking alternative therapeutic options.
✕Less likely to help
Patients who do not have substance use disorders or those who are not interested in psychedelic therapies may not benefit from this research.
What this research studies
This research investigates the therapeutic mechanisms of psychedelics, particularly those containing tryptamine, in treating substance use disorders (SUDs). By utilizing advanced mass spectrometry techniques, the study aims to identify and characterize new chemical probes that can interact with specific serotonin receptors. This approach seeks to improve the understanding of how these compounds alleviate symptoms associated with SUDs, potentially leading to more effective treatments. Patients may benefit from insights gained about the natural products that could be used in therapy.
Why it matters
Potential benefit: If successful, this research could lead to new, more effective treatments for individuals struggling with substance use disorders.
How similar studies have gone: Previous research has shown promise in using psychedelics for treating substance use disorders, indicating that this approach may yield significant insights.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Christopher, Michael — University of Florida
- Study coordinator: Christopher, Michael
Related research
Other NIH-funded projects on the same topics.
-
Improving contraception decisions for women with substance use disorders after childbirth
A patient-centered decision tool called MyPath aims to help postpartum women with substance use disorders choose and keep effective contraception after giving birth.
-
Transforming prison care for HIV, HIV risk, and substance use disorders
A patient-friendly look at improving HIV care and prevention for people in state prisons, especially where substance use is common.
-
Genetic factors behind alcohol and opioid use disorders and depression in veterans
A study using genetic data from veterans to understand how genes contribute to co-occurring alcohol use, prescription opioid use, and depression.
-
Written Exposure Therapy for Veterans with PTSD and Substance Use Disorder (brief trauma treatment)
A brief trauma-focused therapy called Written Exposure Therapy is being studied to help veterans who have both PTSD and substance use disorders.
-
Web-based training to treat PTSD and substance use together in Veterans
A web-based training resource helps VA clinicians learn how to provide integrated treatment for Veterans with both PTSD and substance use disorders.
-
Mobile health support to help Veterans with substance use disorders function better after treatment
A smartphone app, based on Motivational Enhancement Therapy, is being developed to help Veterans stay on track and function better after leaving residential substance use treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.